1
2
#OpenInnovation
3
4
News & Events
InterVenn Biosciences Welcomes Accomplished Diagnostics Executive Joshua Stahl as CEO
September 27, 2023
Joshua Stahl has been appointed as Chief Executive Officer to guide the company's next phase of commercial growth. Read more
FDA Updates for the Week of July 17, 2023
July 22, 2023
The FDA has cleared several new products this week. Read more
Allecra Therapeutics Submits New Drug Application to the U.S. FDA for EXBLIFEP®
June 27, 2023
Cefepime/enmetazobactam is a 4th generation antibiotic for the treatment of complicated urinary tract infections. Read more
5
#knowledgebase
6
7
News & Events
InterVenn Biosciences Welcomes Accomplished Diagnostics Executive Joshua Stahl as CEO
September 27, 2023
Joshua Stahl has been appointed as Chief Executive Officer to guide the company's next phase of commercial growth. Read more
FDA Updates for the Week of July 17, 2023
July 22, 2023
The FDA has cleared several new products this week. Read more
Allecra Therapeutics Submits New Drug Application to the U.S. FDA for EXBLIFEP®
June 27, 2023
Cefepime/enmetazobactam is a 4th generation antibiotic for the treatment of complicated urinary tract infections. Read more
8
Portfolio Highlights
#PharmaBiotech
11
Our View
10
Our Focus
12
#PRI
22
Medical Technologies
#Portfolio
14
Championing
collaborations
that improve health
and the quality of life
for everyone.
#JoinForces
#LifeSciencesInTheFuture
16
Words from
the CEO
17
Portfolio Highlights
#PharmaBiotech
28
Pharmaceutical Biotech
#Portfolio
15
About Us
34
Biorenewables & Others
#Portfolio
19
WHAT'S TRENDING @ XERAYA
Intervenn Appoints Joshua Stahl as CEO
20
Our Team
21
23
Portfolio Highlights
#Biorenewables
30
Portfolio Highlights
#MedTech
25
26
ARE YOU
The Next
Big Thing?
Submit
A
Proposal
29
36
Career
#Xeraya
35
37
News & Events
InterVenn Biosciences Welcomes Accomplished Diagnostics Executive Joshua Stahl as CEO
September 27, 2023
Joshua Stahl has been appointed as Chief Executive Officer to guide the company's next phase of commercial growth. Read more
FDA Updates for the Week of July 17, 2023
July 22, 2023
The FDA has cleared several new products this week. Read more
Allecra Therapeutics Submits New Drug Application to the U.S. FDA for EXBLIFEP®
June 27, 2023
Cefepime/enmetazobactam is a 4th generation antibiotic for the treatment of complicated urinary tract infections. Read more
32
#agro
33
Portfolio Highlights
#Biorenewables
38
Portfolio Highlights
#MedTech
39
40
Contact Us
41
